Berkshire Directs $11.6 Billion to Buybacks as Insurance Weakens

Berkshire Hathaway used about $9.6 billion to repurchase its own shares in the third quarter and, according to Reuters, bought roughly $2 billion more in October. The acceleration is notable because it arrived while third-quarter operating earnings fell 5.8% and insurance underwriting weakened sharply.

The judgment

Implication: The repurchases are a management valuation signal, but not proof that the stock is undervalued. Their quality depends on the price paid relative to Berkshire’s conservatively estimated intrinsic value and on the returns available from acquisitions, operating investment and Treasury bills.

What would change the conclusion: A sustained deterioration in insurance economics, materially better external investment opportunities, or evidence that repurchases were executed above a defensible intrinsic-value range would weaken the case. Stronger recurring operating cash flow and continued per-share value creation would strengthen it.

Management action: Boards evaluating buybacks should require a side-by-side capital-allocation bridge: expected return from repurchases, organic investment, acquisitions, debt reduction and liquid reserves, with explicit downside cases rather than an EPS-only rationale.

The number is large, but the policy matters more

Berkshire’s November 7 earnings release reported $9.6 billion of third-quarter repurchases, bringing the nine-month total to $14.4 billion. Reuters reported a further roughly $2 billion in October. That means the company directed about $11.6 billion toward its own shares across the third quarter and the following month.

The authorization is intentionally open-ended. Berkshire’s filing says the chief executive, after consultation with the chairman, may repurchase shares when the price is below intrinsic value, conservatively determined. The program has no maximum amount or expiration date, and repurchases cannot reduce consolidated cash, cash equivalents and U.S. Treasury bills below $30 billion.

That policy makes the buyback a capital-allocation judgment, not a scheduled distribution. The relevant question is not whether Berkshire has enough cash—it plainly does—but whether each repurchased share offers a better risk-adjusted return than the next acquisition, operating project or liquid investment.

Cash remains abundant after acquisitions and repurchases

At September 30, Berkshire reported $352.3 billion of cash, cash equivalents and U.S. Treasury bills in its insurance and other businesses, net of payables for Treasury-bill purchases that settled in October. The balance sheet separately showed $36.0 billion of cash and equivalents and $336.7 billion of short-term Treasury bills before the related $20.5 billion payable. Reuters used a broader cash-and-equivalents figure of $356.9 billion. The definitions differ, but the conclusion does not: Berkshire retained exceptional liquidity.

The company also deployed capital outside the buyback. It paid approximately $9.4 billion for OxyChem in January and $6.8 billion for Taylor Morrison in July. During the first nine months, operating activities generated $33.9 billion of cash, while capital expenditures totaled $16.1 billion, including $10.2 billion at BNSF and Berkshire Hathaway Energy.

This is why treating the repurchases as a simple “cash hoard finally spent” story misses the decision. Berkshire is simultaneously funding acquisitions, infrastructure-heavy subsidiaries and shareholder returns while preserving a very large liquidity reserve.

Operating weakness raises the standard for the buyback

Third-quarter operating earnings fell to $12.705 billion from $13.485 billion a year earlier. Insurance underwriting earnings declined 42.9% after tax, and GEICO’s pre-tax underwriting earnings dropped to $982 million from $1.773 billion.

The filing shows why. GEICO’s loss ratio increased 5.1 percentage points to 76.6%, reflecting higher claim frequency and severity as well as lower average earned premiums per policy. Its expense ratio also increased as commissions and advertising costs rose. Several retail businesses reported sluggish demand tied to competition, economic uncertainty and weaker consumer confidence.

Those pressures do not make the repurchase wrong. They make price discipline more important. Buying shares during a period of operating softness can create value if the market price discounts temporary weakness more heavily than the underlying economics justify. It destroys value if management mistakes a cyclical or structural earnings problem for a temporary quotation.

A buyback should compete with every other use of cash

Berkshire’s framework is useful beyond Berkshire because it treats repurchases as an investment. A board should compare the expected per-share return with the return from capital spending, acquisitions, debt reduction and the yield available on liquid assets. As discussed in When the Risk-Free Rate Hits 5%, Every Capital Allocation Decision Changes, cash now has a visible opportunity cost.

The same sequencing question appears when companies suspend repurchases. Flutter’s buyback pause reflected a need to protect liquidity and reduce leverage. Berkshire sits at the opposite end of the balance-sheet spectrum, but the governing test is the same: allocate the next dollar where it has the strongest risk-adjusted return.

What investors should watch next

• Repurchase price: Whether purchases continue after Berkshire’s recent share-price strength.
• Per-share operating value: Whether earnings and book value per share improve after adjusting for acquisition effects and investment-market volatility.
• Insurance economics: GEICO loss frequency, severity, pricing and advertising efficiency.
• Capital alternatives: The size and economics of future acquisitions, infrastructure spending and external securities purchases.
• Liquidity definition: Cash and Treasury bills net of settlement payables, not only the larger headline balance.

The conclusion is therefore narrower than “buybacks are bullish.” Berkshire’s actions indicate that management judged its own shares attractive relative to available alternatives. Whether that judgment creates value will be visible in future per-share cash generation, not in the repurchase headline alone.

Sources and evidence

• Berkshire Hathaway, third-quarter 2026 Form 10-Q, November 7, 2026.
• Berkshire Hathaway, third-quarter earnings release, November 7, 2026.
• Reuters, Berkshire Hathaway speeds up stock buybacks, though profit falls, November 7, 2026.

Financial results, repurchase amounts and policy terms are reported facts or management disclosures. The capital-allocation interpretation, board framework and monitoring recommendations are Numbers & Judgment analysis.